Your browser doesn't support javascript.
loading
A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery.
Zhang, Xinghai; Zhang, Huajun; Li, Tingting; Chen, Shaohong; Luo, Feiyang; Zhou, Junhui; Zheng, Peiyi; Song, Shuyi; Wu, Yan; Jin, Tengchuan; Tang, Ni; Jin, Aishun; Yang, Chengyong; Cheng, Guofeng; Gong, Rui; Chiu, Sandra; Huang, Ailong.
Afiliação
  • Zhang X; CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, Hubei, China.
  • Zhang H; CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, Hubei, China.
  • Li T; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China.
  • Chen S; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, 400010, China.
  • Luo F; CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, Hubei, China.
  • Zhou J; University of Chinese Academy of Sciences, 100049, Beijing, China.
  • Zheng P; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China.
  • Song S; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, 400010, China.
  • Wu Y; CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, Hubei, China.
  • Jin T; University of Chinese Academy of Sciences, 100049, Beijing, China.
  • Tang N; Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, Anhui, China.
  • Jin A; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China.
  • Yang C; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, 400010, China.
  • Cheng G; CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, Hubei, China.
  • Gong R; Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, Anhui, China.
  • Chiu S; Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, 400010, China.
  • Huang A; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China.
Signal Transduct Target Ther ; 7(1): 301, 2022 08 30.
Article em En | MEDLINE | ID: mdl-36042204
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article